0
Definium Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−93.9
FY22:
−66.3
FY23:
−93.9
FY24:
−104
FY25:
−166
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−91.8
FY25:
−155
(positive)
Change from FY21 to FY25
millions USD
FY21:
−94.2
FY22:
−56.8
FY23:
−95.7
FY24:
−109
FY25:
−184
(positive)
Change from FY21 to FY25
millions USD
FY21:
−93.0
FY22:
−56.8
FY23:
−95.7
FY24:
−109
FY25:
−184
All amounts in millions USD